Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
In Latest US OTC Switch, Ivermectin 0.5% Lice Treatment Becomes Fully Nonprescription
Oct 27 2020
•
By
Malcolm Spicer
Arbor Pharmaceuticals’ Sklice was approved for OTC sales after being the only Rx ivermectin 0.5% approved for lice treatment available in the US.
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Rx-to-OTC Switch
More from Health